Juno upsizes proposed IPO

Juno Therapeutics Inc. (Seattle, Wash.) amended its proposed IPO on NASDAQ and now plans to sell 9.3 million shares at $21-$23. At $22, Juno would raise $203.5 million and be valued at $1.7 billion. Last week, the oncology company proposed to sell the same number of shares at $15-$18.

The company filed in November to raise up to $150 million. Morgan Stanley; JPMorgan; Goldman Sachs; and Leerink are underwriters. ...